Anemia, or a shortage of healthy red blood cells, may have a greater impact on quality of life than ongoing red blood cell destruction — the hallmark of paroxysmal nocturnal hemoglobinuria (PNH) — despite treatment in people with the rare acquired disease, a real-world study suggests. Individuals with significant…
Discussion
Last in a series. Read part one. In my last column, I discussed when it might be time to consider a bone marrow transplant for paroxysmal nocturnal hemoglobinuria (PNH). But considering it and actually deciding to move forward are two very different things. If that conversation ever becomes…
Discussion
First in a series. Living with paroxysmal nocturnal hemoglobinuria (PNH) has taught me that some of the hardest decisions aren’t the ones we have to make today — they’re the ones we know we may have to face someday. For me, one of those decisions is the possibility of…
Discussion
Use of an experimental infusion therapy for paroxysmal nocturnal hemoglobinuria (PNH) helped increase the levels of hemoglobin — the oxygen-carrying protein in red blood cells — while reducing the need for blood transfusions among participants in a small trial. Data show the mid-stage clinical trial testing HSK39297, in the…
Get regular updates delivered to your inbox.
